Hydrazonylthiazole Derivatives as Dual EGFR and ALR2 Inhibitors: Design, Synthesis, and Comprehensive In Vitro and In Silico Evaluation for Potential Anticancer Activity.
Saved in:
| Title: | Hydrazonylthiazole Derivatives as Dual EGFR and ALR2 Inhibitors: Design, Synthesis, and Comprehensive In Vitro and In Silico Evaluation for Potential Anticancer Activity. |
|---|---|
| Authors: | Sever, Belgin1,2 (AUTHOR), Türkeş, Cüneyt2,3 (AUTHOR), Demir, Yeliz3,4 (AUTHOR), Elamin, Khaled M.4,5 (AUTHOR), Osman, Wadah5,6 (AUTHOR), Oral, Kübra1,6 (AUTHOR), Akıncı Genç, Selenay1,7 (AUTHOR), Cantürk, Zerrin7,8 (AUTHOR), Masunaga, Takuya2,9 (AUTHOR), Kishimoto, Naoki5,8,10 (AUTHOR), Misumi, Shogo1,5,8 (AUTHOR), Otsuka, Masami2,9 (AUTHOR), Fujita, Mikako2,3 (AUTHOR), Ciftci, Halilibrahim2,4,9,10 (AUTHOR) hciftci@mehmetakif.edu.tr |
| Source: | Pharmaceuticals (14248247). Jan2026, Vol. 19 Issue 1, p50. 27p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 14248247 |
|---|---|
| DOI: | 10.3390/ph19010050 |
